The makers of a non-hormonal male contraceptive just announced a key milestone during their first human clinical trials, with ...

Contraline reached a critical milestone in passing Phase I of clinical human trials for ADAM an injectable hydrogel for men ...

The ADAM contraceptive is a hydrogel injected into the male sperm ducts to block the passage of sperm, and it seems to still be effective two years into the first human clinical trial.

Six decades after the first oral contraceptive for women was approved in the United States, University of Minnesota ...

After condoms and vasectomies, male contraception is finally stepping into the future, with YCT-529 paving the way. This ...

A non-hormonal male contraceptive that prevents sperm ... depression and increase cholesterol. The female contraceptive pill — which contains synthetic versions of female hormones estrogen ...

A new male contraception has been shown in trials to last for at least two years, in a critical milestone moment. The implantable, non-hormonal male contraceptive, known as Adam, is a water ...

The decades-long dream of creating a male equivalent of 'the pill' is moving closer to reality. Scientists in the US have begun testing a hormone-free contraceptive tablet in men called YCT-529.

Among this year’s highlights are the initial safety results from the first-in-human trial of ADAM™, an innovative hydrogel developed as a reversible, non-hormonal male contraceptive.

Contraception for women has seen little change over the past 50 years, with the most prevalent contraceptive pills containing ...

YCT-529, developed by US scientists, moves to early-stage phase 2 trial in New Zealand. Study published in Nature ...